Cargando…

Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: A meta-analysis of observational studies

AIMS: To estimate the prevalence of established diabetes and its association with the clinical severity and in-hospital mortality associated with COVID-19. DATA SYNTHESIS: We systematically searched PubMed, Scopus and Web of Science, from 1st January 2020 to 15th May 2020, for observational studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Alessandro, Byrne, Christopher D., Zheng, Ming-Hua, Targher, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258796/ https://www.ncbi.nlm.nih.gov/pubmed/32571616 http://dx.doi.org/10.1016/j.numecd.2020.05.014

Ejemplares similares

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
por: Zhang, Xin-Lei, et al.
Publicado: (2022)

Patients with diabetes are at higher risk for severe illness from COVID-19
por: Targher, G., et al.
Publicado: (2020)

The E/e’ ratio difference between subjects with type 2 diabetes and controls. A meta-analysis of clinical studies
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies
por: Bellinato, F., et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
por: Valbusa, Filippo, et al.
Publicado: (2017)

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
por: Miao, Lei, et al.
Publicado: (2022)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis
por: Maurelli, Martina, et al.
Publicado: (2023)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
por: Mantovani, Alessandro, et al.
Publicado: (2016)

NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management
por: Lonardo, Amedeo, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications
por: Lonardo, Amedeo, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Whole-blood hypocoagulable profile correlates with a greater risk of death within 28 days in patients with severe sepsis
por: Boscolo, Annalisa, et al.
Publicado: (2020)

Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2020)

Comparison of Two Creatinine-Based Estimating Equations in Predicting All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2012)

Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
por: Gao, Feng, et al.
Publicado: (2021)

Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease
por: Miao, Lei, et al.
Publicado: (2022)

Higher Levels of Plasma Hyaluronic Acid and N-terminal Propeptide of Type III Procollagen Are Associated With Lower Kidney Function in Children With Non-alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
por: Bonapace, Stefano, et al.
Publicado: (2014)

Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study
por: Gao, Feng, et al.
Publicado: (2021)

Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
por: Targher, Giovanni, et al.
Publicado: (2020)

COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
por: Feng, Gong, et al.
Publicado: (2020)

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
por: Zheng, Kenneth I., et al.
Publicado: (2020)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
por: Li, Qing, et al.
Publicado: (2019)

Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study
por: Han, Ji Min, et al.
Publicado: (2023)

Greater preferences for death in hospital and mechanical ventilation at the end of life among non-whites recently diagnosed with cancer
por: Boyce-Fappiano, David, et al.
Publicado: (2021)

Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease
por: Ballestri, Stefano, et al.
Publicado: (2021)

Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD
por: Bilson, Josh, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
por: Zhou, Xiao-Dong, et al.
Publicado: (2022)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

High Prevalence of Diabetes in Hospitalized Patients With COVID-19 and Its Association With Greater Severity of COVID-19 in Delhi, India
por: Mithal, Ambrish, et al.
Publicado: (2021)

Type 2 Diabetes and Dietary Carbohydrate Intake of Adolescents and Young Adults: What Is the Impact of Different Choices?
por: Bonsembiante, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i3iqc7rtu1o3kissh51nsagi5s